Merdad Parsey - 10 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Issuer symbol
GILD
Transactions as of
10 Mar 2022
Net transactions value
-$203,010
Form type
4
Filing time
14 Mar 2022, 21:20:07 UTC
Previous filing
13 Apr 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,455 +9.3% 40,613 10 Mar 2022 Direct F1
transaction GILD Common Stock Options Exercise +4,157 +10% 44,770 10 Mar 2022 Direct F1
transaction GILD Common Stock Tax liability $203,010 -3,505 -7.8% $57.92 41,265 10 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,455 -11% 28,634 10 Mar 2022 Common Stock 3,455 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -4,157 -15% 24,477 10 Mar 2022 Common Stock 4,157 Direct F1, F3
transaction GILD Restricted Stock Unit Award +27,840 +114% 52,317 10 Mar 2022 Common Stock 27,840 Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +171,670 $0.000000 171,670 10 Mar 2022 Common Stock 171,670 $57.92 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.